JunHe Assists Ambrx Biopharma in its Listing on the New York Stock Exchange

2021.07.03

On June 18, 2021, Ambrx Biopharma Inc. ("Ambrx Biopharma", stock ticker: AMAM) made an initial offering of American Depositary Shares ("ADSs") and listed on the New York Stock Exchange. Ambrx Biopharma offered 7,000,000 ADSs (excluding overallotment rights) at an offering price of USD $18 per share, raising total funds of USD $126 million.

Ambrx Biopharma, headquartered in San Diego, California, is a clinical-stage biopharmaceutical research and development company. The company uses extended genetic cryptography technology to develop engineered biologicals, including antibody-drug conjugate (ADC), immunomodulatory proteins, bispecific antibodies, and other modified therapeutic proteins.

JunHe acts as the PRC counsel to the underwriters Goldman Sachs, BofA Securities and Cowen in this project and conducted legal due diligence, and reviewed and revised the application and offering documents relating to this offering for Ambro Biopharma’s PRC subsidiaries and onshore R&D cooperation projects.

The lead partner of this project was Mr. LI, Chenliang.

JunHe is the only Chinese law firm to be admitted as a member of Lex Mundi and Multilaw, two international networks of independent law firms. JunHe and selected top law firms in major European and Asian jurisdictions are “best friends.” Through these connections, we provide high quality legal services to clients doing business throughout the world.

As the first carbon neutrality fund sponsored by a law firm in China, the BAF Carbon Neutrality Special Fund was jointly established by JunHe and the Beijing Afforestation Foundation (BAF) to promote carbon neutral initiatives, and encourage social collaboration based on the public fundraising platform to mobilize engagement in public welfare campaigns.

京公网安备11010102005423号

Site Map

Legal Notice

JunHe Assists Ambrx Biopharma in its Listing on the New York Stock Exchange

JunHe and StarRoute Technology Assist LongSing in Issuing Hong Kong's First Green Transportation Asset Tokenized Notes

JunHe Assists Transwarp’s Chapter 18C Listing in Hong Kong

JunHe Assists Sinolong New Materials in its Public Issuance of Convertible Corporate Bonds

JunHe Assists a Leading Company in Completing its First Tokenized RWA with Gold as the Underlying Asset

JunHe Collaborates with Finloop in Assisting Guofu Quantum to Launch a Canadian Oil and Gas RWA

JunHe Assists WestGene Biopharma and CREATE in its Strategic Licensing and Collaboration Agreement